Cardiovascular Disease
Gout-prone genetic profile predicts higher cardiovascular disease risk
A genetic predisposition for gout predicts an increased risk for cardiovascular disease, but a healthy lifestyle can curb that risk, according to data published in RMD Open.
VIDEO: Culinary-based nutrition training increases knowledge, confidence among residents
Culinary medicine, particularly when directed at cardiovascular disease prevention, can be feasibly taught to medical trainees, an analysis presented at the Lifestyle Medicine Conference showed.
Sleep, mood, pain disorders most common comorbidities in those with narcolepsy
Individuals with narcolepsy were significantly more likely to have sleep, mood and pain disorders compared with matched controls, indicating where treatment may best target common comorbidities, according to new research from Sleep Advances.
Semaglutide linked to reduced albuminuria for adults with CKD without diabetes
SAN DIEGO — Semaglutide, a GLP-1 receptor agonist approved for treatment of obesity and type 2 diabetes, improved kidney metrics for adults with overweight and obesity without diabetes, according study data.
In-hospital mortality elevated in cystic fibrosis cardiac hospitalizations
BOSTON — Hospitalization for a cardiac cause vs. a noncardiac cause in patients with cystic fibrosis yielded elevated in-hospital mortality, according to a presentation at the CHEST Annual Meeting.
Oral semaglutide prevents CV events in people with diabetes and heart disease, CKD
Oral semaglutide demonstrated an approximately 14% reduction in major adverse CV events compared with standard care along in patients with diabetes, CVD and/or kidney disease, according to the top-line results of the phase 3 SOUL trial.
Likelihood for cardiovascular diseases reduced in bronchiectasis vs. COPD
Fewer patients with bronchiectasis vs. COPD had at least one cardiovascular comorbidity/risk factor, according to results published in Respiratory Medicine.
Canagliflozin tied to improved iron, hemoglobin levels with type 2 diabetes, CKD
Canagliflozin was associated with increased iron utilization and improved hemoglobin levels for adults with type 2 diabetes and chronic kidney disease, according to data published in Nephrology Dialysis Transplantation.
Hypertension common, predicted by older age, diabetes in early rheumatoid arthritis
Hypertension is common in patients with early rheumatoid arthritis, and most frequently develops in older patients and those with traditional cardiovascular risk factors, according to data published in Rheumatology Advances in Practice.
Top in endocrinology: Tirzepatide: shortage over, more effective than other obesity drugs
The FDA announced that tirzepatide, a GIP/GLP-1 dual agonist approved for the treatment of type 2 diabetes and obesity, has been removed from its drug shortage list.